| Peter M Barkin, MD | |
|
131 Ornac, Suite 660, Concord, MA 01742-4181 | |
| (978) 369-4238 | |
| (978) 369-8323 |
| Full Name | Peter M Barkin |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 41 Years |
| Location | 131 Ornac, Concord, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144298621 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 52191 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Emerson Hospital - | W concord, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emerson Practice Associates, Inc | 8123188117 | 192 |
News Archive
Scientists at The Scripps Research Institute (TSRI) and the Salk Institute for Biological Studies have discovered how a mutant protein triggers nerve damage in a subtype of Charcot-Marie-Tooth (CMT) diseases, a group of currently untreatable conditions that cause loss of function in a person's hands and feet.
"GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor countries," Reuters reports.
The lab of Rice University synthetic organic chemist K.C. Nicolaou has reported the streamlined total synthesis of delta12-prostaglandin J3, a molecule previously claimed to kill leukemic cancer cells.
A University of Washington Medical Center patient on Thursday, Oct. 21, will be the world's first recipient of a device that aims to quell the disabling vertigo associated with Meniere's disease.
Family carers for children and adults with intellectual disabilities have reported rates of mental health problems under lockdown that are up to 10 times higher than parents without those responsibilities, a new study has found.
› Verified 3 days ago
| Entity Name | Emerson Practice Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508020199 PECOS PAC ID: 8123188117 Enrollment ID: O20081120000518 |
News Archive
Scientists at The Scripps Research Institute (TSRI) and the Salk Institute for Biological Studies have discovered how a mutant protein triggers nerve damage in a subtype of Charcot-Marie-Tooth (CMT) diseases, a group of currently untreatable conditions that cause loss of function in a person's hands and feet.
"GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor countries," Reuters reports.
The lab of Rice University synthetic organic chemist K.C. Nicolaou has reported the streamlined total synthesis of delta12-prostaglandin J3, a molecule previously claimed to kill leukemic cancer cells.
A University of Washington Medical Center patient on Thursday, Oct. 21, will be the world's first recipient of a device that aims to quell the disabling vertigo associated with Meniere's disease.
Family carers for children and adults with intellectual disabilities have reported rates of mental health problems under lockdown that are up to 10 times higher than parents without those responsibilities, a new study has found.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter M Barkin, MD 131 Ornac, Suite 660, Concord, MA 01742-4181 Ph: (978) 369-4238 | Peter M Barkin, MD 131 Ornac, Suite 660, Concord, MA 01742-4181 Ph: (978) 369-4238 |
News Archive
Scientists at The Scripps Research Institute (TSRI) and the Salk Institute for Biological Studies have discovered how a mutant protein triggers nerve damage in a subtype of Charcot-Marie-Tooth (CMT) diseases, a group of currently untreatable conditions that cause loss of function in a person's hands and feet.
"GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor countries," Reuters reports.
The lab of Rice University synthetic organic chemist K.C. Nicolaou has reported the streamlined total synthesis of delta12-prostaglandin J3, a molecule previously claimed to kill leukemic cancer cells.
A University of Washington Medical Center patient on Thursday, Oct. 21, will be the world's first recipient of a device that aims to quell the disabling vertigo associated with Meniere's disease.
Family carers for children and adults with intellectual disabilities have reported rates of mental health problems under lockdown that are up to 10 times higher than parents without those responsibilities, a new study has found.
› Verified 3 days ago
Dr. William Judson Burtis, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 747 Main St, Suite 123, Concord, MA 01742 Phone: 978-287-9590 Fax: 978-287-5700 | |
C Gregory Martin, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 133 Ornac, Concord, MA 01742 Phone: 978-287-3111 Fax: 978-287-3675 | |
Dr. Paul David D'ambrosio, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2284 Main St, Concord, MA 01742 Phone: 978-369-5575 Fax: 978-371-9189 | |
Richard P Schwartz, MD PC Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 131 Ornac Ste 510, John Cuming Building, Concord, MA 01742 Phone: 978-776-6186 Fax: 978-776-6189 | |
Thomas Lamattina, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 131 Ornac, Concord, MA 01742 Phone: 978-371-0796 | |
Dr. Peter Scott Benjamin, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 133 Ornac, Concord, MA 01742 Phone: 978-287-3627 | |
Stephen M Dyda, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 131 Ornac, Concord, MA 01742 Phone: 978-287-8767 |